Drug name - Norliqva

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11253474 CMP DEV LLC Pharmaceutical solution of amlodipine Feb, 2041

(18 years from now)

Drugs and Companies using AMLODIPINE BESYLATE ingredient

Treatment: Norliqva is indicated for the treatment of hypertension, to lower blood pressure in adults and children 6 years of age and older; norliqva is indicated for the symptomatic treatment of chronic stable angina; norliqva is indicated for the treatment of confirmed or suspected vasospastic angina

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 1MG BASE/ML SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.